The corelation of pharmaceutical services with the incidence of side effects of phase III COVID vaccination participants in RS Tingkat II Udayana

Iwan Saka Nugraha; Wahyuni W. Udi

doi:10.21744/ijhms.v5n4.1944

Authors

Iwan Saka Nugraha
saka.nugraha1@gmail.com
Department of Clinical and Community Pharmacy STIKES Bali Wisnu Dharma, Indonesia
Wahyuni W. Udi Department of Clinical and Community Pharmacy STIKES Bali Wisnu Dharma, Indonesia

Keywords:

COVID-19, Pharmaceutical Services, Side Effects, Vaccination

Abstract

Background Presiden Regulation No. 99 of 2020 requires Indonesian citizens to vaccinate against COVID-19 to prevent the transmission and severity of COVID-19. Pharmaceutical services are a tangible manifestation in realizing a comfortable and safe COVID-19 vaccination to reduce the risk of side effects Objective: this study aims to study the relationship of pharmaceutical services to the incidence of side effects of covid-19 vaccination after III at RS Tingkat II Udayana. Method: The reseach desaign was cross-sectional study which used analytical survey The population in the study was all participants of the COVID-19 vaccine in June at RS Tingkat II Udayana as many as 500 people. The sample in this study used a total sampling technique. Data collection in this study used primary data. Data analysis is carried out univariately and bivariately. Results: Participants in the third phase of vaccination were dominated by Astrazeneca vaccination users 245 people (49%), no history of comorbidities 435 people (87%), vaccination participants had a normal BMI of 310 people (62%),normal glucose level of 490 (98%), and normal tension of 450 people (90%). The results showed that patients were satisfied with pharmaceutical services related to handling side effects of fever, muscle pain and fatigue.

Downloads

Download data is not yet available.

References

Akbarov, A. N., & Xabilov, D. N. U. (2021). The condition of the oral cavity in patients who have had a viral infection COVID-19. International Journal of Health & Medical Sciences, 4(4), 381-383. https://doi.org/10.21744/ijhms.v4n4.1796

Andreas, G., Thomas, T., Theodore, E. W., Karin, W., Paul, K. & Sabine, E. (2021). A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination. Research Square.

Chui, M. A., Mott, D. A., & Maxwell, L. (2012). A qualitative assessment of a community pharmacy cognitive pharmaceutical services program, using a work system approach. Research in Social and Administrative Pharmacy, 8(3), 206-216. https://doi.org/10.1016/j.sapharm.2011.06.001

Dearnaley, D. P., Khoo, V. S., Norman, A. R., Meyer, L., Nahum, A., Tait, D., ... & Horwich, A. (1999). Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. The Lancet, 353(9149), 267-272. https://doi.org/10.1016/S0140-6736(98)05180-0

Depkes RI, 2016. Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan kefarmasian di Rumah sakit..Jakarta: Kementrian Kesehatan Republik Indonesia

Earle, K. A., Ambrosino, D. M., Fiore-Gartland, A., Goldblatt, D., Gilbert, P. B., Siber, G. R., ... & Plotkin, S. A. (2021). Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine, 39(32), 4423-4428. https://doi.org/10.1016/j.vaccine.2021.05.063

Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., ... & Hamlyn, J. (2020). Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. The Lancet, 396(10249), 467-478. https://doi.org/10.1016/S0140-6736(20)31604-4

Gilat, R., & Cole, B. J. (2020). COVID-19, medicine, and sports. Arthroscopy, sports medicine, and rehabilitation, 2(3), e175-e176. https://doi.org/10.1016/j.asmr.2020.04.003

Gregório, J., Russo, G., & Lapão, L. V. (2016). Pharmaceutical services cost analysis using time-driven activity-based costing: A contribution to improve community pharmacies' management. Research in Social and Administrative Pharmacy, 12(3), 475-485. https://doi.org/10.1016/j.sapharm.2015.08.004

Kemenkes RI, ITAGI, UNICEF & WHO. (2020). Survei Penerimaan Vaksin Covid-19 di Indonesia.Jakarta: Kementrian Kesehatan Republik Indonesia

Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858

Khubchandani, J., & Macias, Y. (2021). COVID-19 vaccination hesitancy in Hispanics and African-Americans: A review and recommendations for practice. Brain, behavior, & immunity-health, 15, 100277. https://doi.org/10.1016/j.bbih.2021.100277

Kim, S. W., & Su, K. P. (2020). Using psychoneuroimmunity against COVID-19. Brain, behavior, and immunity, 87, 4-5. https://doi.org/10.1016/j.bbi.2020.03.025

Leng, A., Maitland, E., Wang, S., Nicholas, S., Liu, R., & Wang, J. (2021). Individual preferences for COVID-19 vaccination in China. vaccine, 39(2), 247-254. https://doi.org/10.1016/j.vaccine.2020.12.009

Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., ... & Jansen, K. U. (2020). Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature, 586(7830), 589-593.

Nasional KPC-19 dan PE. (2020). Data Sebaran Kasus COVID-19 di Indonesia.

Permenkes RI No.147/ Menkes/Per/I/2010. Tentang Perizinan Rumah Sakit. Jakarta.

Presiden RI. Peraturan Presiden Nomor 99 Tahun 2020 tentang Pengadaan Vaksin dan Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19). Jakarta: Presiden RI; 2020

Putri, D. R. (2017). Pengaruh kualitas pelayanan kefarmasian terhadap kepuasan, kepercayaan, & loyalitas konsumen apotek. Indonesian Journal for Health Sciences, 1(1), 23-29.

Ramasamy, M. N., Minassian, A. M., Setiyo Adi Nugroho, Ewer, , A. J.et all. (2021). Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a singleblind, randomised, controlled, phase 2/3 trial. Lancet, 396, 1979-1993.

Robert, C., Soria, J. C., Spatz, A., Le Cesne, A., Malka, D., Pautier, P., ... & Le Chevalier, T. (2005). Cutaneous side-effects of kinase inhibitors and blocking antibodies. The lancet oncology, 6(7), 491-500. https://doi.org/10.1016/S1470-2045(05)70243-6

van de Pol, J. M., Koster, E. S., Hövels, A. M., & Bouvy, M. L. (2019). How community pharmacists prioritize cognitive pharmaceutical services. Research in Social and Administrative Pharmacy, 15(9), 1088-1094. https://doi.org/10.1016/j.sapharm.2018.09.012

Zainafree, I., & Respati, S. A. (2016). Hubungan Mutu Pelayanan Kesehatan dengan Tingkat Kepuasan Pasien Rawat Inap di Puskesmas Halmahera Kota Semarang. VISIKES: Jurnal Kesehatan Masyarakat, 15(1).